Filing Details

Accession Number:
0001179110-17-013135
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-04 20:32:44
Reporting Period:
2017-10-02
Accepted Time:
2017-10-04 20:32:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527710 Patrick James Tursi C/o Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Disposition 2017-10-02 9,960 $2.50 257,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on October 1, 2017. 7,284 of such restricted stock units were previously granted on October 1, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016.
  2. This transaction was executed in multiple trades at prices ranging from $2.50 to $2.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.